Corrigendum: Therapeutic drug monitoring of anti-thymocyte globulin in allogeneic stem cell transplantation: proof of concept

Autor: J. I. Meesters-Ensing, R. Admiraal, L. Ebskamp, A. Lacna, J. J. Boelens, C. A. Lindemans, S. Nierkens

Publikováno v: Frontiers in Pharmacology, Vol 15 (2024)

Externí odkaz: https://doaj.org/article/e6ba3523eb7a494997d10fec7eb32077

Therapeutic Drug Monitoring of Anti-Thymocyte Globulin in Allogeneic Stem Cell Transplantation: Proof of Concept

Autor: J.I. Meesters-Ensing, R. Admiraal, L. Ebskamp, A. Lacna, J. J. Boelens, C. A. Lindemans, S. Nierkens

Publikováno v: Frontiers in Pharmacology, Vol 13 (2022)

Anti-thymocyte globulin (ATG), a polyclonal antibody, is used in allogeneic hematopoietic cell transplantation (HCT) to prevent graft-vs.-host-disease (GvHD) and graft failure (GF). Overexposure to ATG leads to poor early T-cell recovery, which is as

Externí odkaz: https://doaj.org/article/3f233c0273734168933c064c19cf104d

Capillary electrophoretic analysis of ionic content in exhaled breath condensate and pH monitoring as a non-invasive method in gastroesophageal reflux disease diagnostics

Autor: Lačná, Júlia, Ďurč, Pavol, Greguš, Michal, Skřičková, Jana, Doubková, Martina, Pokojová, Eva, Kindlová, Dagmar, Dolina, Jiří, Konečný, Štefan, Foret, František, Kubáň, Petr

Publikováno v: In Journal of Chromatography B 15 December 2019 1134-1135

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Lymphoid and myeloid immune cell reconstitution after nicotinamide-expanded cord blood transplantation

Autor: de Koning, Coco, Tao, Weiyang, Lacna, Amelia, van Veghel, Karin, Horwitz, Mitchell E., Sanz, Guillermo, Jagasia, Madan H., Wagner, John E., Stiff, Patrick J., Hanna, Rabi, Cilloni, Daniela, Valcarcel, David, Peled, Tony, Cohen, Einat Galamidi, Goshen, Uri, Pandit, Aridaman, Lindemans, Caroline A., Boelens, Jaap Jan, Nierkens, Stefan

Publikováno v: BONE MARROW TRANSPLANTATION
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Omidubicel (nicotinamide-expanded cord blood) is a potential alternative source for allogeneic hematopoietic cell transplantation (HCT) when an HLA-identical donor is lacking. A phase I/II trial with standalone omidubicel HCT showed rapid and robust

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::2d1e2d52acde783480ebb6d30fcd1a1f
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=14333